NEW YORK--(BUSINESS WIRE)--Neurogene Inc., a company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced results of a well ...
For patients who are unable to take medication by mouth, the tablet may be dispersed in a dosing cup and administered via NG tube or G tube. The Food and Drug Administration (FDA) has approved an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback